Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06251297

Feasibility and Benefits of Reflexology in the Prevention of Neuropathy Induced by Oxaliplatin in Colorectal Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The management of colorectal cancer often requires oxaliplatin-based chemotherapy, either as part of curative treatment plans or exclusively in palliative situations. Oxaliplatin therefore plays a key role in the management of colorectal cancer. In addition to its digestive and hematological toxicity, oxaliplatin frequently induces chronic, often limiting, sensitive peripheral neuropathy. Only early discontinuation of oxaliplatin can limit the risk of clinically limiting neurotoxicity (grade ≥ 3). In oncology, managing the side-effects of treatment is an essential objective of supportive care, and is open to a variety of complementary medicines, including reflexology. This technique, derived from traditional Chinese medicine, involves stimulating reflex points on the arch of the foot.

Detailed description

This first monocentric, prospective pilot study is designed to evaluate if the intervention is feasible in routine clinical practice for patients initiating bimonthly oxaliplatin chemotherapy for colorectal cancer. It will also provide initial estimates of the parameters needed to measure efficacy and impact on patient quality of life. Patients will receive a reflexology session with each cycle of chemotherapy, and will be assessed during all the treatment period.

Conditions

Interventions

TypeNameDescription
OTHERFoot reflexology30 minutes reflexology session

Timeline

Start date
2024-04-29
Primary completion
2026-05-01
Completion
2026-12-31
First posted
2024-02-09
Last updated
2025-04-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06251297. Inclusion in this directory is not an endorsement.